{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T18:55:41Z","timestamp":1781895341885,"version":"3.54.5"},"reference-count":37,"publisher":"Radcliffe Medical Media Ltd","license":[{"start":{"date-parts":[[2020,3,25]],"date-time":"2020-03-25T00:00:00Z","timestamp":1585094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/legalcode"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>There seems to be a unique interplay between 2019 novel coronavirus (SARS-CoV-2) and cardiovascular diseases, although it is predominantly a respiratory illness. Patients with pre-existing cardiovascular co-morbidities appear to be at highest risk for mortality from coronavirus disease 2019 (COVID-19) along with the elderly; COVID-19 also contributes to cardiovascular complications, including acute coronary syndromes, arrhythmias, myocarditis, acute heart failure, and, in the most severe cases, cardiogenic shock and death. Several medications proposed in the treatment of COVID-19 require cardiac monitoring owing to their cardiac-specific adverse effects. Ultimately, the COVID-19 pandemic has jeopardized the safety of heart transplantation and has placed transplant recipients on immunosuppressive therapies at significant risk. In this article, the authors summarize the rapidly emerging data on the cardiovascular implications of SARS-CoV-2 and COVID-19.<\/jats:p>","DOI":"10.15420\/usc.2020.14","type":"journal-article","created":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T10:46:10Z","timestamp":1585046770000},"source":"Crossref","is-referenced-by-count":12,"title":["COVID-19 Pandemic and Cardiovascular Disease"],"prefix":"10.15420","volume":"14","author":[{"given":"Aniket S","family":"Rali","sequence":"first","affiliation":[{"name":"Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, Baylor College of Medicine, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J","family":"Sauer","sequence":"additional","affiliation":[{"name":"ivision of Advanced Heart Failure and Heart Transplantation, Department of Cardiovascular Medicine, University of Kansas Health System, Kansas City, Kansas."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6096","published-online":{"date-parts":[[2020,3,25]]},"reference":[{"key":"ref0","unstructured":"Wuhan Municipal Health Commission. Report of clustering pneumonia of unknown etiology in Wuhan City. Wuhan: Wuhan Municipal Health Commission, 2019 [in Chinese]. http:\/\/wjw.wuhan.gov.cn\/front\/web\/showDetail\/2019123108989 (accessed March 23, 2020)."},{"key":"ref1","unstructured":"Lu R, Zhao X, Li J et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020;395:565\u201374. https:\/\/doi.org\/10.1016\/S0140-6736(20)30251-8; PMID: 32007145."},{"key":"ref2","unstructured":"Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020;579:270\u20133. https:\/\/doi.org\/10.1038\/s41586-020-2012-7; PMID: 32015507."},{"key":"ref3","unstructured":"Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;382:727\u201333. https:\/\/doi.org\/10.1056\/NEJMoa2001017; PMID: 31978945."},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Zhang JJ, Dong X, Cao YY, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy 2020. https:\/\/doi.org\/10.1111\/all.14238; PMID: 32077115; epub ahead of press.","DOI":"10.1111\/all.14238"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020. https:\/\/doi.org\/10.1001\/jama.2020.1585; PMID: 32031570; epub ahead of press.","DOI":"10.1001\/jama.2020.1585"},{"key":"ref6","unstructured":"Xu XW, Wu XX, Jiang XG, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ 2020;368:m606 https:\/\/doi.org\/10.1136\/bmj.m606; PMID: 32075786."},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Arentz M, Yim E, Klaff L, et al. Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State. JAMA 2020. https:\/\/doi.org\/10.1001\/jama.2020.4326; PMID: 32191259; epub ahead of press.","DOI":"10.1001\/jama.2020.4326"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Nguyen JL, Yang W, Ito K, et al. Seasonal influenza infections and cardiovascular disease mortality. JAMA Cardiol 2016;1:274\u201381. https:\/\/doi.org\/10.1001\/jamacardio.2016.0433; PMID: 27438105.","DOI":"10.1001\/jamacardio.2016.0433"},{"key":"ref9","unstructured":"Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020. https:\/\/doi.org\/10.1016\/S0140-6736(20)30566-3; PMID: 32171076; epub ahead of press."},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Lippi G, Lavie CJ, Sanchis-Gomar F. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): evidence from a meta-analysis. Prog Cardiovasc Dis 2020. https:\/\/doi.org\/10.1016\/j.pcad.2020.03.001; PMID: 32169400; epub ahead of press.","DOI":"10.1016\/j.pcad.2020.03.001"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Lippi G, Plebani M. Laboratory abnormalities in patients with COVID-2019 infection. Clin Chem Lab Med 2020. https:\/\/doi.org\/10.1515\/cclm-2020-0198; PMID: 32119647; epub ahead of press.","DOI":"10.1515\/cclm-2020-0198"},{"key":"ref12","unstructured":"van Doremalen N, Bushmaker T, Morris DH, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med 2020. https:\/\/doi.org\/10.1056\/NEJMc2004973; PMID: 32182409; epub ahead of press."},{"key":"ref13","unstructured":"Hui H, Zhang Y, Yang X, et al. Clinical and radiographic features of cardiac injury in patients with 2019 novel coronavirus pneumonia. MedRxiv 2020. https:\/\/doi.org\/10.1101\/2020.02.24.20027052; epub ahead of press."},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Stadler K, Ha HR, Ciminale V, et al. Amiodarone alters late endosomes and inhibits SARS coronavirus infection at a post-endosomal level. Am J Respir Cell Mol Biol 2008;39:142\u20139. https:\/\/doi.org\/10.1165\/rcmb.2007-0217OC; PMID: 18314540.","DOI":"10.1165\/rcmb.2007-0217oc"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Alhogbani T. Acute myocarditis associated with novel Middle East respiratory syndrome coronavirus. Ann Saudi Med 2016;36:78\u201380. https:\/\/doi.org\/10.5144\/0256-4947.2016.78; PMID:\u00a026922692.","DOI":"10.5144\/0256-4947.2016.78"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Hu H, Ma F, Wei X, Fang Y. Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin. Eur Heart J 2020. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa190; PMID: 32176300; epub ahead of press.","DOI":"10.1093\/eurheartj\/ehaa190"},{"key":"ref17","unstructured":"Chen C, Zhang XR, Ju ZY, He WF. Advances in the research of cytokine storm mechanism induced by corona virus disease 2019 and the corresponding immunotherapies]. Zhonghua Shao Shang Za Zhi 2020 [in Chinese]. https:\/\/doi.org\/10.3760\/cma.j.cn501120-20200224-00088; PMID: 32114747; epub ahead of press."},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Fung SY, Yuen KS, Ye ZW, et al. A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses. Emerg Microbes Infect 2020;9:558\u201370. https:\/\/doi.org\/10.1080\/22221751.2020.1736644; PMID: 32172672.","DOI":"10.1080\/22221751.2020.1736644"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Chu CM, Cheng VC, Hung IF, et al. Role of lopinavir\/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax 2004;59:252\u20136. https:\/\/doi.org\/10.1136\/thorax.2003.012658; PMID: 14985565.","DOI":"10.1136\/thorax.2003.012658"},{"key":"ref20","unstructured":"Cao, B. Wang Y, Wen D, et al. A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19. N Engl J Med 2020. https:\/\/doi.org\/10.1056\/NEJMoa2001282; PMID: 32187464; epub ahead of press."},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Kitahara K, Nakamura Y, Tsuneoka Y, et al. Cardiohemodynamic and electrophysiological effects of anti-influenza drug oseltamivir in vivo and in vitro. Cardiovasc Toxicol 2013;13:234\u201343. https:\/\/doi.org\/10.1007\/s12012-013-9202-6; PMID: 23420508.","DOI":"10.1007\/s12012-013-9202-6"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Frommeyer G, Mittelstedt A, Wolfes J, et al. The anti-influenza drug oseltamivir reduces atrial fibrillation in an experimental whole-heart model. Naunyn Schmiedebergs Arch Pharmacol 2017;390:1155\u201361. https:\/\/doi.org\/10.1007\/s00210-017-1415-y; PMID: 28780600.","DOI":"10.1007\/s00210-017-1415-y"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Savarino A, Di Trani L, Donatelli I. New insights into the antiviral effects of chloroquine. Lancet Infect Dis 2006;6:67\u20139. https:\/\/doi.org\/10.1016\/S1473-3099(06)70361-9; PMID: 16439323.","DOI":"10.1016\/s1473-3099(06)70361-9"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Yan Y, Zou Z, Sun Y, et al. Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model. Cell Res 2013;23:300\u20132. https:\/\/doi.org\/10.1038\/cr.2012.165; PMID: 23208422.","DOI":"10.1038\/cr.2012.165"},{"key":"ref25","unstructured":"Vincent MJ, Bergeron E, Benjannet S, et al. Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virol J 2005;2:69. https:\/\/doi.org\/10.1186\/1743-422X-2-69; PMID: 16115318."},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Yao X, Ye F, Zhang M, et al. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis 2020. https:\/\/doi.org\/10.1093\/cid\/ciaa237; PMID: 32150618; epub ahead of press.","DOI":"10.1093\/cid\/ciaa237"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Chatre C, Roubille F, Vernhet H, et al. Cardiac complications attributed to chloroquine and hydroxychloroquine: a systematic review of the literature. Drug Saf 2018;41:919\u201331. https:\/\/doi.org\/10.1007\/s40264-018-0689-4; PMID: 29858838.","DOI":"10.1007\/s40264-018-0689-4"},{"key":"ref28","unstructured":"Chen Y, Guo Y, Pan Y, Zhao ZJ. Structure analysis of the receptor binding of 2019-nCoV. Biochem Biophys Res Commun 2020. https:\/\/doi.org\/10.1016\/j.bbrc.2020.02.071; PMID: 32081428; epub ahead of press."},{"key":"ref29","unstructured":"Arai T, Yasuda Y, Takaya T, et al. ACE inhibitors and reduction of the risk of pneumonia in elderly people. Am J Hypertens 2000;13:1050\u20131. https:\/\/doi.org\/10.1016\/s0895-7061(00)00301-0; PMID: 10981561."},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Shinohara, Y, Origasa H. Post-stroke pneumonia prevention by angiotensin-converting enzyme inhibitors: results of a meta-analysis of five studies in Asians. Adv Ther 2012;29:900\u201312. https:\/\/doi.org\/10.1007\/s12325-012-0049-1; PMID: 22983755.","DOI":"10.1007\/s12325-012-0049-1"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Caldeira D, Alarc\u00e3o J, Vaz-Carneiro A, Costa J. Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis. BMJ 2012;345:e4260. https:\/\/doi.org\/10.1136\/bmj.e4260; PMID: 22786934.","DOI":"10.1136\/bmj.e4260"},{"key":"ref32","unstructured":"de Simone G. Position statement of the ESC Council on Hypertension on ACE-inhibitors and angiotensin receptor blockers. March 13, 2020. https:\/\/www.escardio.org\/Councils\/Council-on-Hypertension-(CHT)\/News\/position-statement-of-the-esc-council-on-hypertension-on-ace-inhibitors-and-ang (accessed March 23, 2020)."},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020;395:507\u201313. https:\/\/doi.org\/10.1016\/S0140-6736(20)30211-7; PMID: 32007143.","DOI":"10.1016\/s0140-6736(20)30211-7"},{"key":"ref34","unstructured":"WHO. Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: interim guidance. March 13, 2020. https:\/\/www.who.int\/publications-detail\/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected (accessed March 23, 2020)."},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Rosenbaum, L. Facing Covid-19 in Italy \u2013 ethics, logistics, and therapeutics on the epidemic\u2019s front line. N Engl J Med 2020. https:\/\/doi.org\/10.1056\/NEJMp2005492; PMID: 32187459; epub ahead of press.","DOI":"10.1056\/nejmp2005492"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Ren ZL, Hu R, Wang ZW, et al. Epidemiological and clinical characteristics of heart transplant recipients during the 2019 coronavirus outbreak in Wuhan, China: a descriptive survey report. J Heart Lung Transplant 2020. https:\/\/doi.org\/10.1016\/j.healun.2020.03.008; epub ahead of press.","DOI":"10.1016\/j.healun.2020.03.008"}],"container-title":["US Cardiology Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.uscjournal.com\/articleindex\/usc.2020.14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T10:14:40Z","timestamp":1614852880000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.uscjournal.com\/articleindex\/usc.2020.14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,25]]},"references-count":37,"URL":"https:\/\/doi.org\/10.15420\/usc.2020.14","relation":{},"ISSN":["1758-390X","1758-3896"],"issn-type":[{"value":"1758-390X","type":"electronic"},{"value":"1758-3896","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3,25]]},"article-number":"e01"}}